Authors (Year) | Type of diabetes | No of studies | Primary outcomes (n = RCTs for meta-analysis) | Other outcomes | Video components |
---|---|---|---|---|---|
Systematic Review and Meta-Analysis | |||||
Anderson A (2022) [47] | Type 2 | 10 | Significant reduction in HbA1c MD − 0.465% (95% CI: − 0.648% to − 0.282%) n = 9 | N/A | 1 study conducted education sessions by interactive videoconferencing, which was effective in improving HbA1c |
Correia J C (2021) [43] | Type 1, type 2 and gestational | 31 | Significant reduction of HbA1c MD −0.38% (95% CI: −0.52% to −0.23%) n = 28 | Significant effect on fasting blood sugar, adherence to treatment, knowledge of diabetes and self-efficacy. No significant effect on BMI, total cholesterol, and triglycerides | 4 studies identified videoconferencing as part of web-based systems, with mean difference of −0.89% (95% CI: −0.85 to 0.08) |
De Groot J (2021) [44] | Type 2 | 43 | Significant reduction in HbA1c MD −0.486% [95% CI −0.561% to −0.410%) n = 43 | Significant reductions in blood pressure, blood glucose, weight. Improved mental and physical QoL | 4 studies used interactive videoconference with mean reduction in HbA1c of 0.845% (95% CI −1.144 to −0.546, P < 0.001) |
Eberle C (2021)[ [32] | Type 2 | 99 | Significant reduction of HbA1c MD −1.15% (95% CI: − 1.84% to –0.45%) n = 2 | Combination of real-time and asynchronous interventions most effective in improving fasting blood glucose, blood pressure, body weight, BMI, and quality of life | 12 studies analysed videoconferencing and video consulting. 8 studies reported clear reduction in HbA1c values. Weekly video conferences showed significant decline is HbA1c and lower fasting blood glucose. No change in BMI, blood pressure and quality of life. In person visits showed significant weight loss |
Faruque L (2017) [31] | Either type 1 or type 2 or both | 111 | Significant reduction of HbA1c MD—0.28%; 95% CI −0.37% to −0.20%) n = 87 | No evidence of effect on QoL or mortality and reduced risk of hypoglycaemia | 5 studies reported healthcare providers initiated communication using videoconferencing and 1 study involved video messaging. Videoconferencing with health care providers mainly included nurses and/or physicians. People with diabetes initiated communications did not involve any video components |
Hangaard S (2021) [45] | Type 2 | 246 | Significant reduction in HbA1c MD −0.415% [95% CI −0.482% to −0.348%) n = 168 | No significant effect on BMI | Not included in search strategy and not reported in results |
Hu Y (2019) [30] | Either type 1 or type 2 or both | 14 | Significant reduction of HbA1c MD −0.28% (95% CI: −0.45% to −0.12%) n = 13 | No significant effect on BMI. MD −0.27; (95% CI:−0.86% to −0.31%); n = 7 | Videoconferencing and video recording were part of search terms. Findings not reported |
Huang Z (2015) [33] | Type 2 | 18 | Significant reduction of HbA1c MD −0.54% (95% CI: −0.75% to −0.34%) n = 18 | No significant differences in BMI, body weight, and hypoglycaemic events | Not reported as part of the interventions or results |
Lee S W H (2017) [20] | Type 2 | 107 | Significant reduction of HbA1c MD −0.43% (95% CI: −0.64% to −0.21%) n = 93 | No significant changes in cardiovascular risk factors, risk of hypoglycaemia and quality of life | 16 studies with telemonitoring and 11 studies with telementoring interventions, some of which included video conferencing |
Marcolino M S (2013) [37] | Type 1 or type 2 | 15 | Significant reduction of HbA1c MD −0.44% (95% CI: −0.61% to −0.26%) n = 13 | Reduction in LDL-cholesterol, no effect on blood pressure and tendency to reduce BMI | 1 study used videoconferencing as part of telemedicine strategies |
Michaud T L (2021) [24] | Type 2 | 17 | Significant reduction of HbA1c MD −0.30% (95% CI: −0.31% to −0.29%) n = 15 | Weight change (kg)—MD of pre-post difference between telehealth and usual care was −0.62 (95% CI: −0.7 to −0.45) | 2 studies had videoconferencing as part of real-time feedback and reported improvement in HbA1c |
Robson N (2021) [48] | Type 2 | 29 | Significant reduction of HbA1c MD −0.18% (95% CI: 0.35% to −0.01%) n = 21 | Significant reduction in outpatient, Emergency Department (ED) visits, planned hospitalisations, and LDL cholesterol levels | 3 studies used video teleconferencing and 1 study found statistically significant reduction in mean HbA1c levels. Other studies reported reduction in BP. 1 study used video education and reported significant reduction in mean HbA1c and significant improvement in body weight, BMI, waist circumference and fasting blood glucose |
So C F (2018) [42] | Either type 1 or type 2 | 7 | Significant reduction of HbA1c MD—0.64% (95% CI: −1.01% to −0.26%) n = 8 | No significant effect on fasting plasma glucose (MD = −0.26%; 95% CI: −1.05% to 0.53%) n = 4 | Not reported as part of the search or telehealth interventions |
Su D (2015) [28] | Either type 1 or type 2 or both | 92 | Significant reduction of HbA1c post intervention varied from −3.2% to 0.70%. Mean ending HbA1c ranged from 6.26% to 9.21%; n = 92 | No significant effect of having a nutritional counselling as part of the telemedicine interventions | 11 studies used teleconference and 2 studies used educational videos. Nutritional counselling via SMS, telephone or videoconference showed similar effects |
Su D (2016) [29] | Either type 1 or type 2 or both | 49 | Significant reduction of HbA1c pre and post-tests varied from 2.2% to 0.5% in intervention groups and from 1.3% to 0.6% in control groups; n = 55 | Most effective for type 2 diabetes than type 1 and among people with diabetes of ages 40 or older. Interventions of 6 months or less showed greater effect than longer programs | 2 studies used videoconferencing and 1 study included video messages. Effect of video conferencing not reported |
Tchero H (2019) [21] | Type 1 and type 2 | 38 | Significant reduction of HbA1c MD −0.37 (95% CI: −0.43% to −0.31%); n = 42 | Most effective for type 2 diabetes than type 1 diabetes; among people with diabetes of ages 40 or older than younger population; and longer duration interventions of over 6 months | 2 studies included interventions using live videoconferencing for remote consultations. 1 study used video messages. Effect of video conferencing not reported |
Wu C (2018) [35] | Type 1 or type 2 | 19 | Significant reduction of HbA1c MD −0.22% (95% CI: −0.28% to −0.15%) n = 16 | Reduction of blood pressure. No change in BMI and quality of life | 2 studies delivered education via videoconferencing. Effect of video conferencing not reported |
Zhai Y K (2014) [25] | Type 2 | 47 | Significant reduction of HbA1c MD −0.37 (95% CI: −0.49% to −0.25%); n = 35 | 2 studies analysed cost-effectiveness and revealed ICERs (Incremental cost-effectiveness ration) of $491 and $29,869 per capita for each unit reduction in HbA1c, for the telephone- and internet-based (includes video conferencing) interventions, respectively | 1 study included live videoconferencing as part of IDEATel internet-based trial. Meta-analysis showed HbA1c reduction of 0.29% (95% CI: 0.12% to 0.46%) |
Systematic Review | |||||
Cassimatis M (2012) [23] | Either type 1 or type 2 or both | 13 | Significant improvement in HbA1c | 5 out of 8 studies reported significant improvements in dietary adherence and physical activity. 4 out of 9 found significant improvement in blood glucose self-management frequency. 8 studies assessed medication adherence and only 3 reported improvements | 1 study found ‘Persistent viewers’, who viewed more than 10 self-care video messages per month experienced a significant reduction in HbA1c of 0.6% over 12 months |
Greenwood D A (2014) [38] | Type 2 | 15 | Significant reduction in HbA1c levels | Not all 7 key elements of structured monitoring recommended by the IDF were included in telehealth remote patient monitoring interventions | 3 studies used provider feedback methods by videoconferencing. 1 study used educational nuggets. Effect of videoconferencing was reported as part of the interventions |
Hossain M M (2019) [27] | NCDs including diabetes | 13 | Significant reduction in HbA1c | Improvement in medication adherence, self-management, and lifestyle modification | 1 study provided access to educational videos to the telephonic follow up intervention group. Significant reduction of HbA1c reported |
Jalil S (2015) [39] | Type 2 | 19 | Mixed results on the effectiveness of telemedicine on medical outcomes | Positive effect on behavioural improvements | 1 study used video instructions. Effect not reported |
Kaveh M H (2021) [22] | Either type 1 or type 2 or both | 18 | Biomedical outcomes: positive effect on glycaemic control; diet and exercise monitoring led to reducing BMI; improved cholesterol and blood pressure | Behavioural outcomes showed self-monitoring and self-efficacy; Psychosocial outcomes improved depression and increased social support. Quality of life improved | 8 studies used videoconference interventions. Effective in improving behavioural outcomes |
Marsh Z (2021) [26] | Either type 1 or type 2 or both | 9 | Significant reduction in HbA1c of 0.8%—1.3% | Enhanced diabetes self-management adherence and increased satisfaction of people with diabetes and HCPs | 4 studies used videoconferencing. Effective in improving HbA1c and enhances communication between people with diabetes and healthcare professionals |
McDaniel C (2021) [46] | Type 1, type 2, or prediabetes | 21 | Motivational Interviewing (MI) based telehealth seems most effective for improving A1C, systolic blood pressure, diabetes self-efficacy, and physical activity behaviours | Significant effect on behaviour change, medications, physical activities, and diabetes knowledge | 1 study solely used videophone calls for nurse practitioner delivered motivational interviews. Identified as a research gap to evaluate the effect |
McLendon S F (2017) [34] | Both type 1 and type 2 | 14 | Significant reduction of (baseline 8.6 ± 0.3% telemedicine vs. 8.9 ± 0.4 usual care; completion 6.6 ± 0.2 telemedicine vs. 8.1 ± 0.2% usual care, P = 0.02) | Improved patient empowerment, self-care, adherence to diet, glucose monitoring, access to specialist care and preference to use technology | All studies included video consultation. Improved glycaemic control after one video consultation and continued to show progress in lowering HbA1c levels |
Mushcab H (2015) [40] | Type 2 | 19 | Real-time management and remote monitoring of T2DM people with type 2 diabetes resulted in a significant decrease in HbA1c level | mixed results for clinical outcome measures such as HbA1c, BMI, and cholesterol level. High acceptance of technology | Studies involving videoconferencing interventions were excluded |
Sim R (2021) [49] | Type 2 | 20 | Higher patient satisfaction could be achieved by understanding patient preferences and technology support | Support for technology adoption. Increases Access and saves time | 2 studies used videoconferencing as part of the interventions- Enablers and barriers identified |
Van Den Berg N (2012) [36] | Cardiovascular and diabetes | 68 (18 diabetes) | Improved glycaemic control for people with diabetes with mean age between 60 and 69 years | Clear trend towards better results for behavioural outcomes, such as adherence to medication or diet, physical activity, self-efficacy, and managing the disease compared to medical outcome-categories | 19 studies delivered telemedicine case management included videoconferencing. Effective in improving personal contact and better outcomes |
Wickramasinghe S I (2016) [41] | Diabetes | 14 | N/A | Enablers and barriers to telemedicine identified | 1 study used videoconferencing for specialist’s consultations. Effective in increasing number of teleconsultations |